Category: Ideas
-

How To Earn $500 A Month From Citigroup Stock Ahead Of Q4 Earnings
in IdeasCitigroup Inc. (NYSE:C) will release its fourth-quarter financial results before the opening bell on Wednesday, Jan. 15. Analysts expect the New York-based company to report quarterly earnings at $1.21 per share, up from 84 cents per share in the year-ago period. Citigroup projects quarterly revenue of $19.42 billion, compared to $17.44 billion a year earlier, according…
-
Insights Into Apple’s Performance Versus Peers In Technology Hardware, Storage & Peripherals Sector
in IdeasIn the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing Apple (NASDAQ:AAPL) alongside its primary competitors in the Technology Hardware, Storage & Peripherals industry. By meticulously examining key financial metrics, market…
-

How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q1 Earnings
in IdeasCommercial Metals Company (NYSE:CMC) will release earnings results for the first quarter before the opening bell on Monday, Jan. 6, 2025. Analysts expect the Irving, Texas-based company to report quarterly earnings at 82 cents per share, down from $1.63 per share in the year-ago period. Commercial Metals is expected to report quarterly revenue of $1.88…
-

Jim Cramer Likes Walmart, Recommends Buying This ‘Very, Very Good’ Financial Stock
in IdeasOn CNBC’s “Mad Money Lightning Round,” Jim Cramer said he likes Walmart Inc. (NYSE:WMT). According to a CNBC report, Walmart started providing body cameras to some of its store-level employees across the U.S. as part of a pilot program testing the technology. Royalty Pharma plc (NASDAQ:RPRX) is a “disappointing” stock, Cramer said. “I want you…
-

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
in IdeasShares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) rose sharply in today’s pre-market trading after the company announced it will report on December 18 interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis. Corvus Pharmaceuticals shares jumped 22.5% to $9.06 in the pre-market trading session. Here are some…
-

SoundHound AI Soars Over 700%: Short Squeeze Potential Has Traders Talking
in IdeasSoundHound AI Inc (NASDAQ:SOUN) stock skyrocketed 713% this year and 173% this month. The company, which specializes in voice AI technology, is trading at an all-time — and 52-week high — of $17.29 on Friday. Chart created using Benzinga Pro SOUN stock’s technical signals are flashing green across the board. Trading well above its eight,…
-

Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
in IdeasTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays slashed the price target for The AES Corporation (NYSE:AES) from $23 to $17. Barclays analyst Nicholas Campanella maintained an Overweight rating. AES shares closed…
-

Disney Stock Forms Golden Cross: Time For ‘Magical’ Rally?
in IdeasIt seems like Disney’s fairy dust is starting to sparkle again — at least on the technical charts. Shares of Walt Disney Co (NYSE:DIS) recently flashed a Golden Cross, a classic bullish signal where the stock’s short-term moving averages cross above its long-term ones. Chart created using Benzinga Pro With a moderately bullish trend and…
-

Toll Brothers, Oracle And 3 Stocks To Watch Heading Into Monday
in IdeasWith U.S. stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Toll Brothers, Inc. (NYSE:TOL) to report quarterly earnings at $4.33 per share on revenue of $3.17 billion after the closing bell, according to data from Benzinga Pro. Toll…
-

Jim Cramer: This Energy Stock Is A ‘Winner,’ But Navitas Semiconductor Is ‘Losing A Lot Of Money’
in IdeasOn CNBC’s “Mad Money Lightning Round,” Jim Cramer said Navitas Semiconductor Corporation (NASDAQ:NVTS) is “losing a lot of money.” On Tuesday, Navitas Semiconductor announced that Dr. Ranbir Singh, formerly executive vice president at Navitas and the founder and CEO of GeneSiC Semiconductor, has been appointed to the company’s board of directors. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)…